43 related articles for article (PubMed ID: 16825811)
1. Adjuvant chemotherapy improves OS in UTUC.
Killock D
Nat Rev Clin Oncol; 2024 Apr; 21(4):251. PubMed ID: 38388707
[No Abstract] [Full Text] [Related]
2. The role of histological subtype and chemotherapy on prognosis of ureteral cancer.
Li J; Song Y; Peng Y; Lin J; Du Y; Qin C; Xu T
J Cancer Res Clin Oncol; 2024 Apr; 150(4):192. PubMed ID: 38613698
[TBL] [Abstract][Full Text] [Related]
3. Prognostic model using postoperative normalization of C-reactive protein levels in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy.
Teishima J; Hirata J; Toge T; Uematsu R; Mita Y; Yoshii T; Nakamura I
Can Urol Assoc J; 2024 Mar; 18(3):E84-E90. PubMed ID: 38507711
[TBL] [Abstract][Full Text] [Related]
4. Impact of adjuvant chemotherapy for patients with locally advanced upper tract urothelial carcinoma in real-world clinical practice.
Teishima J; Hirata J; Toge T; Uematsu R; Mita Y; Yoshii T; Nakamura I
Can Urol Assoc J; 2024 Jan; 18(1):E32-E36. PubMed ID: 37812794
[TBL] [Abstract][Full Text] [Related]
5. The role of perioperative chemotherapy for upper tract urothelial carcinoma patients treated with radical nephroureterectomy.
Pinar U; Calleris G; Grobet-Jeandin E; Grande P; Benamran D; Thibault C; Gontero P; Rouprêt M; Seisen T
World J Urol; 2023 Nov; 41(11):3205-3230. PubMed ID: 36905443
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant chemotherapy after radical nephroureterectomy improves the survival outcome of high-risk upper tract urothelial carcinoma patients with cardiovascular comorbidity.
Luo Y; Feng B; Wei D; Han Y; Li M; Zhao J; Lin Y; Hou Z; Jiang Y
Sci Rep; 2020 Oct; 10(1):17674. PubMed ID: 33077839
[TBL] [Abstract][Full Text] [Related]
7. Does perioperative chemotherapy improve survival in upper tract urothelial carcinoma? A population based analysis.
Goldberg H; Klaassen Z; Chandrasekar T; Sayyid R; Kulkarni GS; Hamilton RJ; Fleshner NE
Oncotarget; 2018 Apr; 9(27):18797-18810. PubMed ID: 29721162
[TBL] [Abstract][Full Text] [Related]
8. Perioperative chemotherapy in upper tract urothelial carcinoma: a comprehensive review.
Aziz A; Dobruch J; Hendricksen K; Kluth LA; Necchi A; Noon A; Rink M; Roghmann F; Seiler R; Gontero P; Kassouf W; Shariat SF; Xylinas E;
World J Urol; 2017 Sep; 35(9):1401-1407. PubMed ID: 28074261
[TBL] [Abstract][Full Text] [Related]
9. Why are upper tract urothelial carcinoma two different diseases?
Szarvas T; Módos O; Horváth A; Nyirády P
Transl Androl Urol; 2016 Oct; 5(5):636-647. PubMed ID: 27785420
[TBL] [Abstract][Full Text] [Related]
10. Perioperative treatments for resected upper tract urothelial carcinoma: a network meta-analysis.
Yang X; Li P; Deng X; Dong H; Cheng Y; Zhang X; Yang C; Tang J; Yuan W; Xu X; Tao J; Li P; Yang H; Lu Q; Gu M; Wang Z
Oncotarget; 2017 Jan; 8(2):3568-3580. PubMed ID: 27683040
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant chemotherapy for locally advanced upper tract urothelial carcinoma: updated results of the Seoul National University Hospital experience.
Kim HS; Lee JS; Jeong CW; Kwak C; Kim HH; Ku JH
Int Braz J Urol; 2015; 41(6):1067-79. PubMed ID: 26742963
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic role of template-based lymphadenectomy in urothelial carcinoma of the upper urinary tract.
Kondo T; Takagi T; Tanabe K
World J Clin Oncol; 2015 Dec; 6(6):237-51. PubMed ID: 26677437
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant chemotherapy improves survival of patients with upper tract urothelial carcinoma.
Porten S; Siefker-Radtke AO; Xiao L; Margulis V; Kamat AM; Wood CG; Jonasch E; Dinney CP; Matin SF
Cancer; 2014 Jun; 120(12):1794-9. PubMed ID: 24633966
[TBL] [Abstract][Full Text] [Related]
14. The efficacy of adjuvant chemotherapy for locally advanced upper tract urothelial cell carcinoma.
Kim TS; Oh JH; Rhew HY
J Cancer; 2013; 4(8):686-90. PubMed ID: 24155781
[TBL] [Abstract][Full Text] [Related]
15. Oncologic outcomes obtained after neoadjuvant and adjuvant chemotherapy for the treatment of urothelial carcinomas of the upper urinary tract: a review.
Cordier J; Sonpavde G; Stief CG; Tilki D
World J Urol; 2013 Feb; 31(1):77-82. PubMed ID: 23053212
[TBL] [Abstract][Full Text] [Related]
16. Perioperative chemotherapy for upper tract urothelial cancer.
Alva AS; Matin SF; Lerner SP; Siefker-Radtke AO
Nat Rev Urol; 2012 Apr; 9(5):266-73. PubMed ID: 22487872
[TBL] [Abstract][Full Text] [Related]
17. The result of adjuvant chemotherapy for localized pT3 upper urinary tract carcinoma in a multi-institutional study.
Kawashima A; Nakai Y; Nakayama M; Ujike T; Tanigawa G; Ono Y; Kamoto A; Takada T; Yamaguchi Y; Takayama H; Nishimura K; Nonomura N; Tsujimura A
World J Urol; 2012 Oct; 30(5):701-6. PubMed ID: 21984472
[TBL] [Abstract][Full Text] [Related]
18. Combining imaging and ureteroscopy variables in a preoperative multivariable model for prediction of muscle-invasive and non-organ confined disease in patients with upper tract urothelial carcinoma.
Favaretto RL; Shariat SF; Savage C; Godoy G; Chade DC; Kaag M; Bochner BH; Coleman J; Dalbagni G
BJU Int; 2012 Jan; 109(1):77-82. PubMed ID: 21631698
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant chemotherapy in the management of pT3N0M0 transitional cell carcinoma of the upper urinary tract.
Lee SE; Byun SS; Park YH; Chang IH; Kim YJ; Hong SK
Urol Int; 2006; 77(1):22-6. PubMed ID: 16825811
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
